Skip to main content
Top
Literature
1.
go back to reference Baik A, Oluwole OO, Johnson DB et al (2021) Mechanisms of Cardiovascular Toxicities Associated with Immunotherapies. Circ Res 128(11):1780–1801 Baik A, Oluwole OO, Johnson DB et al (2021) Mechanisms of Cardiovascular Toxicities Associated with Immunotherapies. Circ Res 128(11):1780–1801
2.
go back to reference Xiao L, Salem JE, Clauss S et al (2020) Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase. Circulation 142(25):2443–2455CrossRef Xiao L, Salem JE, Clauss S et al (2020) Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase. Circulation 142(25):2443–2455CrossRef
3.
go back to reference Stoltzfus KC, Zhang Y, Sturgeon K et al (2020) Fatal heart disease among cancer patients. Nat Commun 11(1):2011CrossRef Stoltzfus KC, Zhang Y, Sturgeon K et al (2020) Fatal heart disease among cancer patients. Nat Commun 11(1):2011CrossRef
4.
go back to reference Zamorano J (2016) An ESC position paper on cardio-oncology. Eur Heart J 37(36):2739–2740CrossRef Zamorano J (2016) An ESC position paper on cardio-oncology. Eur Heart J 37(36):2739–2740CrossRef
5.
go back to reference Rassaf T, Totzeck M, Backs J et al (2020) Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology. Clin Res Cardiol 109(10):1197–1222 Rassaf T, Totzeck M, Backs J et al (2020) Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology. Clin Res Cardiol 109(10):1197–1222
6.
go back to reference Moslehi J, Fujiwara K, Guzik T (2019) Cardio-oncology: a novel platform for basic and translational cardiovascular investigation driven by clinical need. Cardiovasc Res 115(5):819–823CrossRef Moslehi J, Fujiwara K, Guzik T (2019) Cardio-oncology: a novel platform for basic and translational cardiovascular investigation driven by clinical need. Cardiovasc Res 115(5):819–823CrossRef
7.
go back to reference Zhang L, Awadalla M, Mahmood SS et al (2020) Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. Eur Heart J 41(18):1733–1743 Zhang L, Awadalla M, Mahmood SS et al (2020) Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. Eur Heart J 41(18):1733–1743
8.
go back to reference Finke D, Heckmann MB, Herpel E et al (2021) Early detection of checkpoint inhibitor-associated myocarditis using (68)Ga-FAPI PET/CT. Front Cardiovasc Med 8:614997CrossRef Finke D, Heckmann MB, Herpel E et al (2021) Early detection of checkpoint inhibitor-associated myocarditis using (68)Ga-FAPI PET/CT. Front Cardiovasc Med 8:614997CrossRef
9.
go back to reference Wei SC, Meijers WC, Axelrod ML et al (2021) A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention. Cancer Discov 11(3):614–625 Wei SC, Meijers WC, Axelrod ML et al (2021) A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention. Cancer Discov 11(3):614–625
10.
go back to reference Lehmann LH, Totzeck M (2020) Establishing an oncocardiology service. Herz 45(7):626–631 Lehmann LH, Totzeck M (2020) Establishing an oncocardiology service. Herz 45(7):626–631
Metadata
Title
The Heidelberg cardio-oncology unit (COUNT)—a possible blueprint for improved care of cardio-oncological patients
Authors
L. H. Lehmann
F. Stein
D. Jäger
N. Frey
Publication date
01-02-2022
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 2/2022
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-021-01894-z

Other articles of this Issue 2/2022

Clinical Research in Cardiology 2/2022 Go to the issue